美国多组体学服务市场规模、份额、趋势分析报告：按服务、类型、应用、最终用途和细分市场预测，2025 年至 2033 年

美国多组体学服务市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，美国多组体学服务市场预计到2033年将达到16.6亿美元，2025年至2033年期间的复合年增长率为17.10%。

随着对整合生物数据的需求不断增长，以更好地了解疾病并加速个人化治疗的发展，市场正在迅速扩张。基因组学、代谢体学、代谢组学和转录组学等多体学技术的进步正在重塑癌症、神经退化性疾病和慢性病等复杂疾病的诊断和治疗方式。研究经费的增加和精准医疗的兴起是推动市场成长的主要因素。

人工智慧与机器学习的融合将进一步加速对复杂资料集的解读，从而在药物开发和临床诊断中做出更快、更准确的决策。这些进步使研究人员能够分析来自多个生物层面的大型整合资料集，从而全面了解疾病机制，并促进新生物标记的识别。

此外，多组体学在药物开发、学术研究和临床诊断等各个领域的应用日益广泛，也推动了市场的成长。肿瘤学、神经病学和罕见疾病治疗领域对个人化和标靶治疗治疗的需求，催生了对多组体学服务的强劲需求。随着监管要求的不断变化，各公司正在扩展其服务范围，投资于旨在简化研究和临床工作流程的创新，并确保提供高品质、合规的多组体学服务。

随着多体学技术的发展，美国多体学服务市场已做好准备，推动全球生物医学研究、加速药物研发，并改善精准医疗解决方案的患者预后。

美国多组体学服务市场报告重点

• 从服务角度来看，研究服务将在2024年主导美国多组体学服务市场，占67.44%的市场占有率。研究人员正在利用多体学方法探索复杂的生物过程，发现新的生物标记物，并深入了解疾病机制。随着肿瘤学、神经病学和罕见疾病等领域对全面、综合的生物数据的需求日益增长，研究服务在推动科学知识和治疗创新方面发挥核心作用。
• 按类型划分，批量多组体学服务在2024年占据了最大的市场占有率，占77.01%。这种主导地位归因于药物研发、生物标记开发和临床诊断领域对大规模多体学分析日益增长的需求。批量多体学服务提供全面且可扩展的解决方案，用于分析大型数据集，整合基因组学、蛋白质组学和代谢体学信息，以更好地理解复杂疾病。批量多组体学能够以高精度和高效率处理大量数据，已成为製药公司、研究机构和临床实验室的重要服务。
• 从应用角度来看，2024年，药物发现和开发占据了美国多组体学服务市场的主导地位，占据了35.52%的市场占有率。多组体学正日益整合到药物开发平臺中，从而能够更准确地识别治疗标靶、优化药物配方，并更深入地了解药物的疗效和安全性。由于精准医疗（尤其是在肿瘤学、神经病学和免疫学领域）日益受到关注，该应用将继续成为市场的关键驱动力。整体情况疾病机制并预测患者对治疗的反应，可以提高药物发现和临床试验的成功率。
• 从最终用途来看，製药和生物技术公司占据主导地位，占2024年美国多组体学市场占有率的44.83%。这些公司在采用多组体学服务来支持药物发现、生物标记开发和个人化医疗方面处于领先地位。对高品质、整合的多体学数据的需求对于简化创新治疗方法的开发和提高临床试验的准确性至关重要。製药公司、生技公司和多体学服务提供者之间的持续合作正在加速下一代治疗方法的开发，并扩大多体学在各个治疗领域的应用。
• 2025 年 4 月，Source Biosciences 将与 CCL 合作，加强其基因组检测和精准医疗能力，以推进诊断解决方案并推动关键医疗保健创新。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

• 市场展望
  • 母市场展望
  • 相关/附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 美国多组体学服务市场分析工具
  • 产业分析-波特五力分析
  • PESTEL分析
  • COVID-19影响分析

第四章美国多组体学服务市场：服务业务分析

• 服务细分仪表板
• 美国多组体学服务市场服务波动分析
• 美国多体学服务市场规模与趋势分析（按服务，2021-2033 年）
• 研究服务
• 数据分析服务

第五章美国多元组体学服务市场：按类型分類的业务分析

• 类型细分仪表板
• 美国多体学服务市场波动分析
• 美国多体学服务市场规模与趋势分析（按类型）（2021-2033）
• 单细胞多组体学
• 批量体学

第六章美国多组体学服务市场：应用业务分析

• 应用程式细分仪表板
• 美国多体学服务市场应用趋势分析
• 美国多体学服务市场规模与趋势分析（按应用，2021-2033 年）
• 生物标誌物发现市场
• 药物研发
• 合成生物学
• 其他的

第七章美国多组体学服务市场：最终用途业务分析

• 最终用途细分仪表板
• 美国多组体学服务市场的最终用途趋势分析
• 美国多组体学服务市场规模和趋势分析（按最终用途）（2021-2033 年）
• 製药和生物技术公司
• 学术研究所
• 其他的

第八章 竞争态势

• 公司分类
• 战略地图
• 2024年企业市场分析
• 公司简介/上市公司
  • Bio-Techne
  • CD Genomics
  • RayBiotech, Inc.
  • . Creative Proteomics
  • Psomagen
  • Source BioScience
  • Persistent Systems
  • Metware Biotechnology Inc.
  • Dalton Bioanalytics Inc.
  • Sapient Bioanalytics, LLC.

U.S. Multiomics Services Market Growth & Trends:

The U.S. multiomics services market is projected to reach USD 1.66 billion by 2033, growing at a CAGR of 17.10% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is expanding rapidly, driven by the growing demand for integrated biological data to enhance disease understanding and accelerate the development of personalized therapies. Advancements in multiomics technologies, such as genomics, proteomics, metabolomics, and transcriptomics, are reshaping how complex diseases, including cancer, neurodegenerative disorders, and chronic conditions, are diagnosed and treated. Increased research funding and the rise of precision medicine are key factors fueling the market's growth.

Integrating AI and machine learning further accelerates the interpretation of complex datasets, enabling faster, more accurate decision-making in drug development and clinical diagnostics. These advancements allow researchers to analyze large-scale, integrated datasets from multiple biological layers, offering a comprehensive view of disease mechanisms and facilitating the identification of new biomarkers.

The market's growth is also driven by the increasing application of multiomics across various sectors, including pharmaceutical development, academic research, and clinical diagnostics. The need for personalized and targeted therapies in oncology, neurology, and rare disease treatments has created a strong demand for multiomics services. With evolving regulatory requirements, companies are expanding their service offerings and investing in innovations that streamline the research and clinical workflows, ensuring high-quality and compliant multiomics services.

As multiomics technologies evolve, the U.S. multiomics services market is positioned to advance biomedical research, accelerate drug discovery, and improve patient outcomes in precision health solutions worldwide.

U.S. Multiomics Services Market Report Highlights:

• By services, research services dominated the U.S. multiomics services market in 2024, accounting for 67.44% of the market share. Researchers are leveraging multiomics approaches to explore complex biological processes, discover new biomarkers, and gain deeper insights into disease mechanisms. As the need for comprehensive, integrated biological data grows in areas like oncology, neurology, and rare diseases, research services play a central role in advancing scientific knowledge and therapeutic innovation.
• By type, bulk multiomics services held the largest market share in 2024, accounting for 77.01% of the market. This dominance can be attributed to the growing demand for large-scale multiomics analysis in drug discovery, biomarker development, and clinical diagnostics. Bulk multiomics services offer comprehensive, scalable solutions for analyzing large datasets, integrating genomics, proteomics, and metabolomics information to enhance understanding of complex diseases. The ability to handle large volumes of data with high precision and efficiency positions bulk multiomics as a key service offering for pharmaceutical companies, research institutions, and clinical labs.
• By application, drug discovery & development dominated the U.S. multiomics services market in 2024, capturing 35.52% of the market share. Multiomics is increasingly being integrated into the drug development pipeline, allowing for more accurate identification of therapeutic targets, optimization of drug formulations, and a better understanding of drug efficacy and safety. This application continues to be a major driver in the market due to the growing focus on precision medicine, particularly in oncology, neurology, and immunology. The ability to provide a holistic view of disease mechanisms and predict patient responses to treatment enhances the success rate of drug discovery and clinical trials.
• By end use, pharmaceutical & biotechnology companies dominated the U.S. multiomics services market in 2024, accounting for 44.83% of the market share. These companies are at the forefront of adopting multiomics services to support drug discovery, biomarker development, and personalized medicine. The demand for high-quality, integrated multiomics data is critical in streamlining the development of innovative therapies and improving the precision of clinical trials. Ongoing collaborations between pharmaceutical companies, biotechnology firms, and multiomics service providers are helping to accelerate the development of next-generation therapies and expand the applications of multiomics across various therapeutic areas.
• In April 2025, Source BioScience collaborated with CCL to strengthen its genomic testing and precision medicine capabilities to advance diagnostic solutions and drive innovations in critical healthcare.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Service Segment
  • 1.2.2. Type Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Multiomics Services Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Multiomics Services Market: Service Business Analysis

• 4.1. Service Segment Dashboard
• 4.2. U.S. Multiomics Services Market Service Movement Analysis
• 4.3. U.S. Multiomics Services Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
• 4.4. Research Services
  • 4.4.1. U.S. Research Services based Market, 2021 - 2033 (USD Million)
• 4.5. Data Analysis Services
  • 4.5.1. U.S. Data Analysis Services Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Multiomics Services Market: Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. U.S. Multiomics Services Market Type Movement Analysis
• 5.3. U.S. Multiomics Services Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Single-cell Multiomics
  • 5.4.1. U.S. Single-cell Multiomics Market, 2021 - 2033 (USD Million)
• 5.5. Bulk Multiomics
  • 5.5.1. U.S. Bulk U.S. Multiomics Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Multiomics Services Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. U.S. Multiomics Services Market Application Movement Analysis
• 6.3. U.S. Multiomics Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Biomarker Discovery Market
  • 6.4.1. U.S. Biomarker Discovery Market, 2021 - 2033 (USD Million)
• 6.5. Drug Discovery & Development
  • 6.5.1. U.S. Drug Discovery & Development Market, 2021 - 2033 (USD Million)
• 6.6. Synthetic Biology
  • 6.6.1. U.S. Synthetic Biology Market, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. U.S. Multiomics Services Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. U.S. Multiomics Services Market End Use Movement Analysis
• 7.3. U.S. Multiomics Services Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Pharmaceutical and Biotechnology Companies
  • 7.4.1. U.S. Pharmaceutical and Biotechnology Companies Devices Market, 2021 - 2033 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. U.S. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Bio-Techne
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Service Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. CD Genomics
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Service Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. RayBiotech, Inc.
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Service Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. . Creative Proteomics
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Service Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Psomagen
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Service Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Source BioScience
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Service Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Persistent Systems
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Service Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Metware Biotechnology Inc.
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Service Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. Dalton Bioanalytics Inc.
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Service Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Sapient Bioanalytics, LLC.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Service Benchmarking
    • 8.4.10.4. Strategic Initiatives

List of Tables

• Table 1 U.S. multiomics services market estimates & forecasts
• Table 2 U.S. multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
• Table 3 U.S. multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
• Table 4 U.S. multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
• Table 5 U.S. multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market snapshot
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market trends & outlook
• Fig. 7 Market segmentation & scope
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 PESTLE Analysis
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Strategy framework
• Fig. 13 Participant categorization
• Fig. 14 U.S. Multiomics Services market: Service outlook key takeaways
• Fig. 15 U.S. Multiomics Services market: Service movement analysis
• Fig. 16 Research Services market, 2021 - 2033 (USD Million)
• Fig. 17 Data Analysis Services market, 2021 - 2033 (USD Million)
• Fig. 18 U.S. Multiomics Services market: Type outlook key takeaways
• Fig. 19 U.S. Multiomics Services market: Type movement analysis
• Fig. 20 Single-cell Multiomics market, 2021 - 2033 (USD Million)
• Fig. 21 Bulk Multiomics market, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Multiomics Services market: Application outlook key takeaways
• Fig. 23 U.S. Multiomics Services market: Application movement analysis
• Fig. 24 Biomarker Discovery market, 2021 - 2033 (USD Million)
• Fig. 25 Drug Discovery & Development market, 2021 - 2033 (USD Million)
• Fig. 26 Synthetic Biology market, 2021 - 2033 (USD Million)
• Fig. 27 Others market, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Multiomics Services market: End Use outlook key takeaways
• Fig. 29 U.S. Multiomics Services market: End Use movement analysis
• Fig. 30 Academic & Research Institutes market, 2021 - 2033 (USD Million)
• Fig. 31 Pharmaceutical and Biotechnology Companies market, 2021 - 2033 (USD Million)
• Fig. 32 Others market, 2021 - 2033 (USD Million)
• Fig. 33 Key companies profiled